Metraipolis › archive › dc_7fe5065fa2e6

Association of SGLT2 inhibitors use with a lower risk of biliary diseases in patients with type 2 diabetes mellitus: a retrospective cohort study — Europe PMC PMID:41622960

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41622960
DOI: 10.1080/07853890.2026.2619263
License (as archived): solo-consultazione
Archived: 2026-11-06T04:31:05.682Z
SHA-256 of the archived text: 770ef5fb376e8879b8ed70323aa348462b416186ebc19a0a99c17a1a18b02925
Stable URL of this page: https://metraipolis.com/documento/dc_7fe5065fa2e6

How to cite

Association of SGLT2 inhibitors use with a lower risk of biliary diseases in patients with type 2 diabetes mellitus: a retrospective cohort study — Europe PMC PMID:41622960 — Europe PMC (en), https://europepmc.org/article/MED/41622960 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7fe5065fa2e6 (Metraipolis archive dc_7fe5065fa2e6, sha256 770ef5fb376e8879b8ed70323aa348462b416186ebc19a0a99c17a1a18b02925)

BibTeX

@misc{dc7fe5065fa2e6,
  title = {Association of SGLT2 inhibitors use with a lower risk of biliary diseases in patients with type 2 diabetes mellitus: a retrospective cohort study — Europe PMC PMID:41622960},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41622960},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7fe5065fa2e6; sha256 770ef5fb376e8879b8ed70323aa348462b416186ebc19a0a99c17a1a18b02925},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41622960. Agents can read the archived copy with the MCP tool read_document.